Poseida Therapeutics
PSTX
#7399
Rank
โ‚ฌ0.27 B
Marketcap
2,87ย โ‚ฌ
Share price
5.12%
Change (1 day)
40.47%
Change (1 year)

Revenue for Poseida Therapeutics (PSTX)

Revenue in 2024 (TTM): โ‚ฌ81.73 Million

According to Poseida Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ82.46 Million. In 2023 the company made a revenue of โ‚ฌ58.53 Million a decrease over the revenue in the year 2022 that were of โ‚ฌ0.12 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Poseida Therapeutics from 2019 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ81.73 M39.64%
2023 โ‚ฌ58.53 M-51.89%
2022 โ‚ฌ0.12 B341.03%
2021 โ‚ฌ27.58 M
2020 N/A
2019 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA